We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Arterial Gas Analyzer and Autoanalyzer Compared for Electrolytes

By LabMedica International staff writers
Posted on 28 Mar 2013
Electrolyte values are measured in most critically ill intensive care unit (ICU) patients using both an arterial blood gas analyzer (ABG) and a central laboratory autoanalyzer (AA). More...


Data on sodium and potassium ion concentrations in ICU patients have been examined to see whether the electrolyte levels assessed by the ABG and the AA are equivalent and reliable.

Scientists at the Sevket Yilmaz Education and Research Hospital (Bursa, Turkey) retrospectively studied patients hospitalized in the ICU between July and August 2011. They identified 84 instances, of 1,105 patient blood gas samples analyzed, in which arterial and venous samples were collected simultaneously and sodium (Na+) and (K+) were measured using two methods.

In the ICU, arterial blood samples were collected in heparinized blood-gas syringes and analyzed using the benchtop pHOx Stat Profile Plus L blood–gas analyzer (Nova Biomedical; Waltham MA, USA) which employs direct ion-specific electrode (ISE) technology. Another sample was drawn, at the same time, from the same arterial sampling point, using a vacuum technique featuring clot-activating tubes. These samples were sent, pneumatically sealed, to the central laboratory, where serum Na+ and K+ concentrations were analyzed via indirect ISE on a Modular ISE900 auto-analyzer (Roche Diagnostics; Mannheim, Germany).

The mean sodium concentration was 138.mmol/L (standard deviation, SD ±10.2 mmol/L) using the ABG and 143.0 mmol/L (SD ±10.5 mmol/L) using the AA, which was statistically different. The mean potassium level was 3.5mmol/L (SD ± 0.9 mmol/L) using the ABG and 3.7 mmol/L (SD ± 1.0 mmol/L) using the AA which was also significantly different. The extent of interanalyzer agreement was unacceptable for both K+ and Na+. The between-day imprecision of both instruments (AA and ABG) was small and lacked clinical significance when compared with analytical performance indicators based on biological variation.

The authors concluded that their study illustrates the importance of determining the concordance, for each individual hospital, of electrolyte values obtained by ABG and those obtained in the central laboratory. As instrument type and calibration methods may differ among hospitals, it is important that each center conducts an in-house study as in their study the ABG and AA do not yield equivalent Na+ and K+ data. The study was published on August 3, 2012, in the BioMed Central journal BMC Anesthesiology.

Related Links:

Sevket Yilmaz Education and Research Hospital
Nova Biomedical
Roche




Gold Member
H-FABP Assay
Heart-Type Fatty Acid-Binding Protein Assay
Online QC Software
Acusera 24•7
New
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Thyroid Test
Anti-Thyroid EIA Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image Credit: Shutterstock

New Biomarkers Predict Resistance to Targeted Therapy in Rare Blood Cancer

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive leukemia with limited treatment options and a poor prognosis. Although tagraxofusp is the first approved targeted therapy for... Read more

Immunology

view channel
Image:Proteomic tear-fluid analysis revealed abnormal patterns in proteins that regulate nerves and T cells in individuals with eye problems (Image Credit: Adobe Stock)

Diagnostic Models Detect Hidden Eye Abnormalities After Mild COVID-19

Persistent ocular symptoms after COVID-19 can severely affect reading, work, and daily tasks, yet standard eye exams often reveal no clear abnormalities. Patients experiencing photophobia, eye pain, and... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.